Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-05-15FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Chartwell RX, LLC)
FDA approved the original application for levocetirizine dihydrochloride (generic) from Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: The Oligonucleotide Chip Analysis for Allergic Rhinitis Treatment in Herbal Plaster and Acupuncture [NA]
This clinical trial evaluated oligonucleotide chip analysis for allergic rhinitis treatment using herbal plaster and acupuncture. The study …
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Biological Standardization of Allergen Extracts of Pollens of Betula Pendula, Phleum Pratense and Mite Extract of Dermatophagoides Pteronyssinus [Phase 2]
A Phase 2 trial update on the biological standardization of allergen extracts from Betula pendula pollen, Phleum pratense pollen, and Dermat…
-
FDA approval · 2017-04-28FDA Approved: ADVIL ALLERGY AND CONGESTION RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for ADVIL ALLERGY AND CONGESTION RELIEF, a combination product containing chlorpheniramine maleate, …
-
FDA approval · 2017-04-28FDA Approved: AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE — Original Application (Apotex Corp.)
FDA approves Apotex's original application for a generic nasal spray combining azelastine hydrochloride with fluticasone propionate for alle…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2017-04-26FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
FDA approved a supplemental application for Claritin (loratadine) by Bayer HealthCare LLC to update the product labeling.
-
FDA approval · 2017-04-24FDA Approved: MONTELUKAST SODIUM — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved a generic Montelukast Sodium product from Rising Pharma Holdings, Inc. under an Original Application (ANDA209012). It provi…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) [Phase 4]
Phase 4 randomized, double-blind, parallel-group, placebo-controlled trial evaluating cetirizine HCl syrup and loratadine syrup against plac…
-
FDA approval · 2017-04-05FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Flonase Sensimist Allergy Relief (fluticasone furoate) submitted by Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: The Effect of Omalizumab on Responses to Cat Allergen Challenge [NA]
This clinical trial evaluated whether omalizumab modulates responses to cat allergen exposure in individuals with allergic rhinitis; the stu…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions [Phase 1]
Phase 1 study assessing the relative bioavailability of cetirizine hydrochloride/pseudoephedrine hydrochloride extended-release tablets unde…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions [Phase 1]
Phase 1 study designed to demonstrate the relative bioavailability of Promethazine HCl 50 mg tablets under fasting conditions.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions [Phase 1]
Phase 1 study to assess the relative bioavailability of cetirizine hydrochloride/pseudoephedrine hydrochloride extended-release tablets unde…
-
FDA label_change · 2017-03-24FDA Approved: ADVIL ALLERGY SINUS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application to update the labeling for ADVIL ALLERGY SINUS, a three-drug combination (chlorpheniramine maleate, …
-
FDA approval · 2017-03-24FDA Approved: ADVIL ALLERGY AND CONGESTION RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Advil Allergy and Congestion Relief, a combination product containing chlorpheniramine maleate, …
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958 [Phase 2]
Follow-up Phase 2 trial assessing the effect of GSK2245035 on nasal allergic reactivity in subjects completing treatment in a prior study; r…
-
CLINICAL_TRIALS research · 2017-03-15Clinical Trial Update: Trial of Tian Jiu Therapy for Allergic Rhinitis [NA]
This clinical trial update shows that the Tian Jiu Therapy study for allergic rhinitis conducted by Hong Kong Baptist University has complet…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607) [Phase 3]
Phase 3 trial update for SCH 900237/MK-8237 in children and adults with perennial and nonseasonal allergic rhinitis/rhinoconjunctivitis; stu…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL [Phase 1]
Phase 1 trial evaluating tolerability and safety of two new doses of Grass MATA MPL for allergic rhinitis has been completed.
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Animal Allergy in Korean Veterinary Researcher
This clinical trial update describes a study on animal allergy conducted by a Korean veterinary researcher. Conditions include allergic rhin…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever [Phase 2]
A Phase 2 exploratory trial evaluated a single dose of QAX576, an interleukin-13 monoclonal antibody, for effects on simulated hayfever in a…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine [Phase 2]
A Phase 2 crossover trial evaluating the combination of QAV680 and cetirizine for allergic rhinitis has completed.
-
FDA approval · 2017-02-16FDA Approved: FLUTICASONE PROPIONATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Fluticasone Propionate submitted by Padagis Israel Pharmaceuticals Ltd.
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627) [Phase 2]
Phase 2 dose-ranging study evaluating the safety and effectiveness of MK-8237 for house dust mite–induced allergic rhinitis/rhinoconjunctivi…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008) [Phase 1]
Phase 1 safety study of MK-8237 in adolescents with house-dust-mite allergic rhinitis has completed with results posted.